UBS Group AG UBS ← Back to all reports

UBS Group AG

UBS · Financials
A ★★★★ Buy
Aug 2, 2026 · Score 85 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $52.76
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $50.50 ($49.00–$52.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $61.50
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+16.6%

Type A - UBS Group AG (UBS) 20260802 Stock Analysis

📅 UBS Key Upcoming Events

🏢 Step 1: UBS Company Overview & Business Model

Q1-A1. What is UBS?

Q1-A2. How Does UBS Make Money?

Q1-A3. UBS’s Revenue Segments & Core Income Sources

Q1-A4. Who Are UBS’s Competitors?

Q1-A5. UBS Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: UBS’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does UBS Have a Durable Economic Moat?

Q2-A2. Is UBS’s Growth Sustainable?

Q2-A3. How Does UBS Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is UBS Profitable? Financial Health Analysis

Q3-A2. How Profitable Is UBS? (Margins & ROIC)

Q3-A3. What Drives UBS’s Returns? (ROIC Breakdown)

Q3-A4. Are UBS’s Earnings High Quality?

Q3-A5. Is UBS’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: UBS Forensic Accounting & Dilution Review

Q4-A1. Does UBS Have Accounting Red Flags?

Q4-A2. Is UBS Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is UBS’s Cash Flow?

Q4-A4. Is UBS Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: UBS Management & Shareholder Alignment

Q5-A1. Can You Trust UBS’s Management? (Guidance Track Record)

Q5-A2. What Are UBS Insiders Doing?

Q5-A3. Is UBS’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: UBS Market Flow & Sentiment

Q6-A1. Analyst Consensus vs UBS Guidance

Q6-A2. What Is UBS’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: UBS Catalysts & Price Triggers

Q7-A1. What Could Move UBS Stock? (Top 3 Catalysts)

Q7-A2. UBS’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is UBS Fairly Valued? Valuation Analysis

Q8-A1. UBS’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. UBS vs Peers: Valuation Comparison

Q8-A3. Is UBS Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into UBS? (Reverse DCF)

Q8-A5. Valuation Cross-Check

Q8-A6. UBS’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of UBS? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to UBS?

Q9-A2. How Sensitive Is UBS to the Economy?

Q9-A3. UBS Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: UBS Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy UBS? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. UBS’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is UBS’s Exposure to the Swiss Government’s Proposed $25 Billion Capital Mandate Its Biggest Weakness?

Q2: Can UBS’s 17x Forward P/E Be Justified by the Credit Suisse Cost Synergies?

Q3: Will the Ongoing AT1 Bond and Archegos Litigation Materially Derail Capital Returns?

Q4: How Sustainable Is the Margin Expansion in Global Wealth Management?

Q5: Will the Decommissioning of 70% of Credit Suisse Legacy IT Create Long-Term Operational Alpha?

Q6: Can the Investment Bank Segment Continue to Deliver 31% Revenue Growth Without Increasing Risk?

Q7: Will the Rapid Wind-Down of the Non-Core and Legacy (NCL) Portfolio Liberate Significant Capital?

Q8: Does the High Institutional Ownership Provide a Structural Floor for the Stock Price?

Q9: Will the Personal & Corporate (P&C) Banking Division Benefit Long-Term from the Monopoly Status?

Q10: Is the Expected 40% EPS Growth Acceleration in FY2027 Realistic?

Rating History

Rating History shows the Rating assigned on each report date. We leave scores out of the timeline because reports from different periods may follow different rating scales. The score remains visible in each report that is still available.

  1. 2026-07 B
  2. 2026-08 A